Lagos, Nigeria – 10 July 2026

This video covers the Annual General Meeting (AGM) of MeCure Industries Plc, held on July 10, 2026. The session served as a platform for reviewing the company's financial results for the 2025 fiscal year and securing shareholder approval for key operational and financial resolutions.

Key Meeting Highlights:

• Strong Financial Growth: Management presented results showing a significant 69% increase in revenue (3:58) and a robust expansion in total assets, driven by the launch of 19 new pharmaceutical products (5:18).
• Dividend Approval: Shareholders officially approved the board's proposal for a final dividend of 32 kobo per share for the 2025 financial year (37:10 - 41:40).
• Strategic Capital Increase: A major resolution was passed to raise the company's additional authorized share capital from Naira 30 billion to Naira 50 billion. This capital is intended to fund the development of a new state-of-the-art site and help restructure the company's balance sheet (5:45, 35:35, 1:02:11).
• Governance & Oversight: The meeting included the re-election of directors (43:10) and the formal appointment of the Statutory Audit Committee, composed of both board and shareholder representatives (50:33 - 53:46).

Shareholder Feedback: Throughout the proceedings, shareholders actively engaged with the board, expressing concerns regarding high finance costs (6:52), the management of trade receivables (3:20, 33:04), and the importance of ensuring product availability across local markets (8:45).

The meeting concluded with a vote of thanks from the Chairman, who reaffirmed the company's commitment to consolidating its market position and driving long-term value for its stakeholders (1:07:19).